Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1

Παρόμοια τεκμήρια

• HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
  ανά: Baran, RW, κ.ά.
  Έκδοση: (2010)
• Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)
  ανά: Tookey, Pat, κ.ά.
  Έκδοση: (2014)
• Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
  ανά: Broder, MS, κ.ά.
  Έκδοση: (2010)
• Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
  ανά: Pereira, A, κ.ά.
  Έκδοση: (2010)
• Lopinavir/ritonavir monotherapy in clinical practice
  ανά: Caso, A, κ.ά.
  Έκδοση: (2010)